Kalaris Therapeutics, Inc. (KLRS) — Long-term Investment Intensity
Kalaris Therapeutics, Inc. (KLRS) has a Long-term Investment Intensity of 7.0% as of March 2026. Long-term investments of $7.65 Million represent 7.0% of total assets of $109.81 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check Kalaris Therapeutics, Inc. cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Annual Long-term Investment Intensity for Kalaris Therapeutics, Inc. (None–None)
The table below presents the year-by-year Long-term Investment Intensity for Kalaris Therapeutics, Inc. from None to None, covering 0 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see Kalaris Therapeutics, Inc. (KLRS) market capitalisation.
| Year | LT Investment Intensity | LT Investments (USD) | Total Assets | Change (pp) |
|---|